Ellington Financial Inc. Other Non-Current Liabilities decreased by 10.7% to $47.37M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 25.0%, from $63.15M to $47.37M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 16.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $14.17M | $14.12M | $12.30M | $16.53M | $20.44M | $7.72B | $54.20M | $24.25M | $30.50M | $38.52M | $61.78M | $40.43M | $44.06M | $49.24M | $71.02M | $63.15M | $81.81M | $60.76M | $53.07M | $47.37M |
| QoQ Change | — | -0.4% | -12.9% | +34.4% | +23.7% | >999% | -99.3% | -55.3% | +25.8% | +26.3% | +60.4% | -34.6% | +9.0% | +11.8% | +44.2% | -11.1% | +29.6% | -25.7% | -12.7% | -10.7% |
| YoY Change | — | — | — | — | +44.3% | >999% | +340.7% | +46.7% | +49.2% | -99.5% | +14.0% | +66.7% | +44.5% | +27.8% | +15.0% | +56.2% | +85.7% | +23.4% | -25.3% | -25.0% |